Penro 500mg 1vial Inj is primarily indicated in conditions like Abdominal sepsis, Adult febrile neutropenia, Gynecological infections, Meningitis, Obstetric infections, Pneumonia, Pulmonary infections in cystic fibrosis, Septicaemia, Serious infections, Surface anaesthetic, Surgical anaesthesia.
Penro 500mg 1vial Inj is contraindicated in conditions like Hypersensitivity, GI diseases.
The severe or irreversible adverse effects of Penro 500mg 1vial Inj , which give rise to further complications include Pseudomembranous colitis, Thrombocytopenia, Stevens johnson syndrome, Stevens johnson syndrome, Eosinophilia, Eosinophilia, Seizures. Penro 500mg 1vial Inj produces potentially life-threatening effects which include Hypersensitivity reactions. which are responsible for the discontinuation or Penro 500mg 1vial Inj therapy. The symptomatic adverse reactions produced by Penro 500mg 1vial Inj are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Vomiting, Diarrhea, Fever, Constipation, Abdominal pain, Rashes, Urticaria, Pruritus, Elevation of liver enzymes, Dermatitis, Reaction at injection site.
Pseudomembranous colitis and hypersensitivity reactions have occured and often require immediate drug discontinuation, thrombocytopenia has been reported in patients with significant renal dysfunction, seizures have occurred in the patient with underlying neurological disorders (less frequent than with Penro 500mg 1vial Inj , safety and efficacy of Penro 500mg 1vial Inj have not been established for children